IMMUNITYBIO, INC. Accumulated Other Comprehensive Income
IMMUNITYBIO, INC. (IBRX) had Accumulated Other Comprehensive Income of $27.28 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $27.28M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $27.45M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $28.96M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.00M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | $27.28M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $27.45M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $28.96M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $5.00M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $12.57M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $19.96M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.20M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $103.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$8.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$7.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $10.00K 10-K · filed 2025-03-03 | |
| 2023-09-30 | $792.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$40.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$33.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $183.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | -$190.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$110.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | -$367.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $4.00K 10-K · filed 2023-03-01 | |
| 2021-09-30 | $53.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $37.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$38.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $122.00K 10-K · filed 2022-03-01 | -$122.00K 10-K · filed 2021-03-04 |
| 2020-09-30 | -$117.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$100.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | -$128.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$87.00K 8-K/A · filed 2021-04-22 | -$105.00K 10-K · filed 2020-03-25 |
| 2019-09-30 | -$53.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | -$84.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | -$206.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | -$267.00K 10-K · filed 2020-03-25 | |
| 2018-09-30 | -$348.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | -$448.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | -$555.00K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | -$381.00K 10-K · filed 2019-03-13 | |
| 2017-09-30 | -$202.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$237.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | -$240.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$284.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $135.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $424.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $318.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$192.00K 10-K · filed 2017-03-15 | |
| 2015-09-30 | -$50.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |